CyTOF analysis of these tumors revealed that the CCR2+ admixed tumors had significantly fewer CD11b+ myeloid cells and significantly increased CD8+ T-cells present within the tumor (Fig. 7c, d). The gene discussed is CD8A; the disease is neoplasm.